Orphenadrine Citrate
Product Images NDC 68788-9150

2 FDA label images from Preferred Pharmaceuticals, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 68788-9150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Orphenadrine Citrate Chemical Structure (7b76c8a7 Dd0c 481c 8299 26dfd38ce066 01)

Orphenadrine Citrate Chemical Structure (7b76c8a7 Dd0c 481c 8299 26dfd38ce066 01)
Chemical structure of Orphenadrine Citrate showing the molecular arrangement of Orphenadrine with citrate salt.*
FDA Label Image

Orphenadrine Citrate Er 100 mg Label (7b76c8a7 Dd0c 481c 8299 26dfd38ce066 02)

Orphenadrine Citrate Er 100 mg Label (7b76c8a7 Dd0c 481c 8299 26dfd38ce066 02)
This image shows a yellow warning and directions panel for Orphenadrine Citrate Extended-Release Tablets 100mg. It includes dosing instructions advising one tablet every 12 hours, warnings about the risk of drowsiness, and cautions against operating machinery or driving after taking this medicine. The panel text is presented in both English and Spanish.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.